(Press-News.org) Researchers at the Department of Biology, University of Copenhagen, have now contributed to solving this problem for a specific gene called GCK. The study has just been published in Genome Biology.
Figure: GCK gene
Rasmus Hartmann-Petersen, Professor at the Department of Biology, explains:
- “The GCK gene, which codes for the enzyme glucokinase, regulates the secretion of insulin in the pancreas. GCK gene variants can therefore cause a form of hereditary diabetes. Although the connection between GCKand diabetes has been known for several years, we have, until now, only known the effect of a few percent of the possible variants of this gene”.
Together with colleagues at the PRISM centre, UCPH, who are currently studying the effects of genetic variations, the researchers measured the effect of all of the possible variants of GCK.
PhD student Sarah Gersing, who is the first author of the article, explains:
- “We used yeast cells to measure the activity of over 9000 different GCK variants. In this way, we were able to generate a list of the effects — both of already known variants, but also of variants that patients might carry, but that have not yet been discovered. This provides us with a reference for future GCK diagnostics”.
Prof. Kresten Lindorff-Larsen, who heads the PRISM centre, continues:
- “Our results are quite unique; not only have we measured the effect of several thousand variants, but for many of the variants, we can now explain what they do to the glucokinase protein. In our centre, we have gathered researchers working across a range of research fields, bridging from data analysis and biophysics to cell biology and medicine, and it is now clear how this broad approach pays off in explaining how diseases arise”.
Gene variants of GCK can, among other things, cause a form of hereditary diabetes called "GCK maturity onset diabetes of the young" (GCK-MODY).
Professor of genetics, dr. med. Torben Hansen, who is also a member of the PRISM centre, says: - "Although GCK-MODY patients exhibit elevated blood glucose levels, this is often not associated with complications. Hence, unlike other forms of diabetes, most GCK-MODY patients might therefore not need to be treated with medication. However, due to missing or inaccurate genetic data, more than half of the GCK-MODY patients are classified with having either type 1 or type 2 diabetes – and are therefore unnecessarily medicated. We estimate that approx. 1% of those who have recently been diagnosed with type 2 diabetes in Denmark have a variant in the GCK gene, meaning that they don’t need treatment, or need to be treated differently. Our new map of GCK variants can hopefully help give these patients a more correct diagnosis.”
The next step for PRISM is to transfer these methods to other genes and diseases.
- "We are already well underway with genes involved in e.g., neurodegenerative diseases, and we are trying to develop precise methods that can provide us with insights on disease mechanisms", says Rasmus Hartmann-Petersen.
Kresten Lindorff-Larsen continues:
- "Our data gives us the opportunity to test and develop computational models for variant effects, which will then be transferable to other genes and diseases."
- “Now, we have measured the effects of almost all variants of GCK, giving us knowledge on which variants that function, and which that do not. The next step is to understand why, and how the same underlying molecular mechanisms can give rise to a wide range of different diseases", concludes Sarah Gersing.
END
High-throughput experiments might ensure a better diagnosis of hereditary diseases
2023-05-03
ELSE PRESS RELEASES FROM THIS DATE:
Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery
2023-05-03
A new technique designed to allow surgeons to identify and remove residual tumor tissue during breast-conserving surgery showed promising results in a multi-center trial led by investigators from the Mass General Cancer Center, a member of Mass General Brigham. The clinical trial, which was funded in part by Lumicell, Inc., evaluated Lumicell’s investigational optical imaging agent pegulicianine in fluorescence-guided surgery (pFGS). In pFGS, pegulicianine is activated to a fluorescent form at sites of residual tumor, allowing surgeons to identify tumor remaining in the surgical site during breast cancer surgery. Investigators found that ...
Eric and Wendy Schmidt announce the 2023 Schmidt Science Fellows
2023-05-03
New York, NY, 3 May 2023 - Today, Eric and Wendy Schmidt announced the members of the 2023 cohort of Schmidt Science Fellows. The 32 exceptional early career scientists will receive support to develop research projects and the leadership skills necessary to harness interdisciplinary science to tackle some of the world’s most intractable problems.
Schmidt Science Fellows is the inaugural program of Schmidt Futures, the philanthropic initiative of Eric and Wendy Schmidt with a mission to find and connect talented people to solve our world’s hardest ...
How to protect consumers from deceptive comparison pricing
2023-05-03
Researchers from Duke University, University of Notre Dame, and Microsoft published a new Journal of Marketing article that examines using “true normal prices” during a sale as a way to reduce deceptive pricing tricks.
The study, forthcoming in the Journal of Marketing, is titled “Competition and the Regulation of Fictitious Pricing” and is authored by Richard Staelin, Joel E. Urbany, and Donald Ngwe.
Does competition make firms more honest? Over 50 years ago, the Federal Trade Commission (FTC) assumed the answer was yes when it stopped enforcing ...
Astronomers find distant gas clouds with leftovers of the first stars
2023-05-03
Using ESO’s Very Large Telescope (VLT), researchers have found for the first time the fingerprints left by the explosion of the first stars in the Universe. They detected three distant gas clouds whose chemical composition matches what we expect from the first stellar explosions. These findings bring us one step closer to understanding the nature of the first stars that formed after the Big Bang.
“For the first time ever, we were able to identify the chemical traces of the explosions of the first stars in very distant ...
Sleep phase can reduce anxiety in people with PTSD
2023-05-03
A new study shows that sleep spindles, brief bursts of brain activity occurring during one phase of sleep and captured by EEG, may regulate anxiety in people with post-traumatic stress disorder (PTSD).
The study shines a light on the role of spindles in alleviating anxiety in PTSD as well as confirms their established role in the transfer of new information to longer-term memory storage. The findings challenge recent work by other researchers that has indicated spindles may heighten intrusive and violent thoughts in people with PTSD.
The final draft of the preprint publishes in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging on ...
New investigators join Stowers Institute for Medical Research
2023-05-03
KANSAS CITY, MO—May 3, 2023—The Stowers Institute for Medical Research announced the hiring of three principal investigators to further expand its team of scientists who seek to answer life’s biggest mysteries through foundational research. Siva Sankari, Ph.D., from Massachusetts Institute for Technology, Neşet Özel, Ph.D., from New York University, and Ameya Mashruwala, Ph.D., from Princeton University, will join the Institute’s current team of 17 principal investigators and staff of 500. The addition of these scientists ...
The biophysicist names Padmini Rangamani as new Editor-in-Chief
2023-05-03
ROCKVILLE, MD – The Biophysical Society is pleased to announce that Padmini Rangamani of the University of California, San Diego has been named as the new Editor-in-Chief of the The Biophysicsist, the Society’s open access education journal. The journal was developed under the leadership and vision of founding and current Editor-in-Chief, Sam Safran of the Weizmann Institute of Science in Rehovot, Israel, to highlight and nurture biophysics education and its scholarship and development.
“Now, more than ever, is the time for an education journal such as The Biophysicist to steer the ...
Gender gap found in research grant award amounts, re-applications
2023-05-03
VANCOUVER, Wash. – Women researchers received substantially less funding in grant awards than men—an average of about $342,000 compared to men’s $659,000, according to a large meta-analysis of studies on the topic.
Women were also less likely to receive second grants to continue their research. In first-time grant applications, proportional numbers of women and men scientists were approved for funding, but for re-applications, 9% fewer women who applied were approved than their male ...
Steep 66% drop in party registration with Automatic Voter Registration
2023-05-03
In 2016, Oregon became the first state to adopt and implement an Automatic Voter Registration (AVR) system. Now, twenty-two states, plus Washington D.C., have such systems in place. Early research on the impacts of this innovation has shown an increase in the number of people registered, and greater diversity among the registrants.
Now, a researcher using Oregon voter data has identified an unintended consequence of Automatic Voter Registration: a steep drop in party registration. These results have been published in the journal Electoral Studies ...
New insights into liver cancer using organoids
2023-05-03
PRESS RELEASE: PRINCESS MÁXIMA CENTER FOR PEDIATRIC ONCOLOGY
EMBARGO: WEDNESDAY 3 MAY 2023 AT 10:00AM BST (11:00AM CEST)
Scientists of the Princess Máxima Center for pediatric oncology and Hubrecht Institute in the Netherlands have revealed new scientific insights into the features of fibrolamellar carcinoma (FLC), a rare type of childhood liver cancer. Their findings, published today in Nature Communications, may help in developing new drug therapies in the future. Mini organs and the ‘molecular scissor’ system CRISPR-Cas9, allowed the researchers to better understand tumor biology and biological ...